Researchers identified miR-149-5p as overexpressed in progressive bronchial premalignant lesions. The microRNA suppresses ...

Throughout a person's lifetime, the cells lining the respiratory tract are exposed to inhaled pollutants, including cigarette ...

Dakota Johnson mentioned, on a talk show that she used to smoke, which is the leading cause of lung cancer. During a candid chat she was having with a host of a talk show, the Madame Webb ...

(Boston)—Throughout a person’s lifetime, the cells lining the respiratory tract are exposed to inhaled pollutants, including cigarette smoke. These exposures can cause molecular changes that disrupt ...

Boots is adding new signage to thousands of stores across the UK to help customers spot early signs and symptoms of lung ...

Detailed price information for Immutep Ltd ADR (IMMP-Q) from The Globe and Mail including charting and trades.

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...

FDA clearance covers pembrolizumab plus paclitaxel ± bevacizumab for PD-L1 CPS ≥1 platinum-resistant disease after one or two prior systemic regimens, introducing PD-1 inhibition into this treatment ...

Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic ...

US FDA approves Agilent’s PD-L1 IHC 22C3 pharmDx, a companion diagnostic indicated to identify patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma Santa Clara, California ...

An oncologist with two decades of experience is begging people not to skip it.

Explore Sun Pharma's strong portfolio, innovative launches, and investment potential amidst market volatility for long-term growth.